Invion Limited (ASX:IVX – Get Free Report) insider Chiat Chew bought 17,861,942 shares of the stock in a transaction on Wednesday, September 4th. The shares were bought at an average price of A$0.00 ($0.00) per share, for a total transaction of A$35,723.88 ($23,815.92).
Invion Price Performance
About Invion
Invion Limited, a clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of various cancers, atherosclerosis, and infectious diseases in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, anogenital, and mesothelioma cancers.
Read More
- Five stocks we like better than Invion
- How to Invest in Blue Chip Stocks
- 3 Leveraged ETFs to Multiply Returns
- What Investors Need to Know to Beat the Market
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Best Aerospace Stocks Investing
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Invion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invion and related companies with MarketBeat.com's FREE daily email newsletter.
